Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CORDLESS- Collagenase Optimal Reduction of Dupuytren's - Long-term Evaluation of Success Study

NCT00954746 is registered in ClinicalTrials.gov with Endo USA Inc., a Keenova Therapeutics Company as lead sponsor.

NCT NCT00954746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00954746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CORDLESS- Collagenase Optimal Reduction of Dupuytren's - Long-term Evaluation of Success Study
Lead sponsor
Endo USA Inc., a Keenova Therapeutics Company
Phase
Observational
Overall status
Completed
Start date
July 31, 2009
Completion date
May 31, 2013
Enrollment
645 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

dupuytren's disease